← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 12, 2023Last known activity
Sep 12, 2025
Acquired by Merck on May 29, 2024
Timeline
2020s
- Jun 1, 2021
EyeBiotech Ltd.— Founded
- May 29, 2024
Merck— Acquired By
Drugs by trial phase (4 distinct, 5 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Recent trials (8)
- NCT07205887OfficialPhase 2Sep 12, 2025
- NCT07205887Lead sponsorPhase 2Sep 12, 2025
- NCT06957080Lead sponsorPhase 2/Phase 3Apr 16, 2025
- NCT06957080OfficialPhase 2/Phase 3Apr 16, 2025
- NCT06664502Lead sponsorPhase 1/Phase 2Oct 31, 2024
- NCT06571045Lead sponsorPhase 2/Phase 3Aug 14, 2024
- NCT06571045OfficialPhase 2/Phase 3Aug 14, 2024
- NCT05919693Lead sponsorPhase 1/Phase 2Jun 12, 2023
Details
- Founded
- London, GB Jun 1, 2021
- Last known activity
- Sep 12, 2025